- Home
- ANEB vs CALC Comparison
ANEB vs CALC Comparison
Compare ANEB & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- CALC
- Stock Information
- Founded
- ANEB 2020
- CALC 2011
- Country
- ANEB United States
- CALC United States
- Employees
- ANEB N/A
- CALC N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- CALC Health Care
- Exchange
- ANEB Nasdaq
- CALC Nasdaq
- Market Cap
- ANEB 36.7M
- CALC 36.0M
- IPO Year
- ANEB 2021
- CALC N/A
- Fundamental
- Price
- ANEB $1.64
- CALC $1.99
- Analyst Decision
- ANEB Buy
- CALC Strong Buy
- Analyst Count
- ANEB 1
- CALC 4
- Target Price
- ANEB $8.00
- CALC $17.25
- AVG Volume (30 Days)
- ANEB 24.3K
- CALC 32.6K
- Earning Date
- ANEB 02-14-2025
- CALC 03-27-2025
- Dividend Yield
- ANEB N/A
- CALC N/A
- EPS Growth
- ANEB N/A
- CALC N/A
- EPS
- ANEB N/A
- CALC N/A
- Revenue
- ANEB N/A
- CALC N/A
- Revenue This Year
- ANEB N/A
- CALC N/A
- Revenue Next Year
- ANEB N/A
- CALC N/A
- P/E Ratio
- ANEB N/A
- CALC N/A
- Revenue Growth
- ANEB N/A
- CALC N/A
- 52 Week Low
- ANEB $0.80
- CALC $1.86
- 52 Week High
- ANEB $3.30
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- ANEB 56.08
- CALC 34.55
- Support Level
- ANEB $0.91
- CALC $2.02
- Resistance Level
- ANEB $1.20
- CALC $2.35
- Average True Range (ATR)
- ANEB 0.17
- CALC 0.23
- MACD
- ANEB 0.01
- CALC 0.00
- Stochastic Oscillator
- ANEB 60.86
- CALC 26.35
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.